Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of alzheimer’s disease

Frontiers in Cellular Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  González Marrero, Ibrahim ^a   Giménez Llort, Lydia ^b   Johanson, Conrad E ^c   Carmona Calero, Emilia María ^a   Castañeyra Ruiz, Leandro ^a   Brito Armas, José Miguel ^a   Castañeyra Perdomo, Agustín ^a   Castro Fuentes, Rafael ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c Brown University Program in Neurosurgery   (United States)

Author keywords

3xTg AD mice; Alzheimer disease; Amyloid ; Aquaporin 1; Choroid plexus; Collagen IV; Dysfunction; Transthyretin

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AQUAPORIN 1; COLLAGEN TYPE 4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PREALBUMIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONFOCAL MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN TRANSPORT;

EID: 84923253287     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00017     Document Type: Article

References (81)

1. Abramowski, D., Rabe, S., Upadhaya, A. R., Reichwald, J., Danner, S., Staab, D., et al. (2012). Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration and functional impairment without typical Alzheimer’s disease pathology. J. Neurosci. 32, 1273-1283. doi: 10.1523/JNEUROSCI.4586-11.2012.
2. Al-Sarraf, H., Ghaaedi, F., and Redzic, Z. (2007). Time course of hyperosmolar opening of the blood-brain and blood-CSF barriers in spontaneously hypertensive rats. J. Vasc. Res. 44, 99-109. doi: 10.1159/000098260.
3. Balda, M. S., and Matter, K. (1998). Tight junctions. J. Cell Sci. 111, 541-547. doi: 10.1007/springerreference:33880.
4. Bayer, T. A., and Wirths, O. (2010). Intracellular accumulation of amyloid-beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer’s disease. Front. Aging. Neurosci. 2:8. doi: 10.3389/fnagi.2010.00008.
5. Behl, M., Zhang, Y., Shi, Y., Cheng, J., Du, Y., and Zheng, W. (2010). Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 31, 524-532. doi: 10.1016/j.neuro.2010.05.004.
6. Boassa, D., and Yool, A. J. (2005). Physiological roles of aquaporins in the choroid plexus. Curr. Top. Dev. Biol. 67, 181-206. doi: 10.1016/s0070-2153(05)67005-6.
7. Borghys, H., Jacobs, T., Van Broeck, B., Dillen, L., Dhuyvetter, D., Gijsen, H., et al. (2014). Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model. J. Alzheimers Dis. 38, 39-48. doi: 10.3233/JAD-130599.
8. Bourasset, F., Ouellet, M., Tremblay, C., Julien, C., Do, T. M., Oddo, S., et al. (2009). Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer’s disease. Neuropharmacology 56, 808-813. doi: 10.1016/j.neuropharm.2009.01.006.
9. Chen, R. L., Kassem, N. A., Redzic, Z. B., Chen, C. P., Segal, M. B., and Preston, J. E. (2009). Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep. Exp. Gerontol. 44, 289-296. doi: 10.1016/j.exger.2008.12.004.
10. Chiu, C., Miller, M. C., Caralopoulos, I. N., Worden, M. S., Brinker, T., Gordon, Z. N., et al. (2012). Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CNS 9:3. doi: 10.1186/2045-8118-9-3.
11. Choi, B. R., Cho, W. H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., et al. (2014). Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Exp. Mol. Med. 46:e75. doi: 10.1038/emm.2013.147.
12. Church, R. M., Miller, M. C., Freestone, D., Chiu, C., Osgood, D. P., Machan, J. T., et al. (2014). Amyloid-Beta accumulation, neurogenesis, behavior and the age of rats. Behav. Neurosci. 4, 523-536. doi: 10.1037/a0036433.
13. Cirrito, J. R., May, P. C., O’Dell, M. A., Taylor, J. W., Parsadanian, M., Cramer, J. W., et al. (2003). In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life. J. Neurosci. 23, 8844-8853. doi: 10.1007/springerreference:35677.
14. Claudio, L. (1996). Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer’s disease patients. Acta Neuropathol. 91, 6-14. doi: 10.1007/s004010050386.
15. Crossgrove, J. S., Li, G. J., and Zheng, W. (2005). The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp. Biol. Med. (Maywood) 230, 771-776.
16. Crossgrove, J. S., Smith, E. L., and Zheng, W. (2007). Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers. Brain Res. 1138, 187-195. doi: 10.1016/j.brainres.2006.12.022.
17. Deane, R., Du, Y. S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., et al. (2003). RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907-913. doi: 10.1038/nm890.
18. Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., et al. (2004). LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344. doi: 10.3410/f.1020568.235474.
19. Dickson, P. W., Aldred, A. R., Marley, P. D., Bannister, D., and Schreiber, G. (1986). Rat choroid plexus specializes in the synthesis and the secretion of transthyretin (prealbumin). Regulation of transthyretin synthesis in choroid plexus is independent from that in liver. J. Biol. Chem. 261, 3475-3478.
20. Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A. 3rd, Silverberg, G. D., Miller, M. C., et al. (2006). RAGE, LRP-1 and amyloid-beta protein in Alzheimer’s disease. Acta Neuropathol. 112, 405-415. doi: 10.1007/s00401-006-0115-3.
21. Dorfman, V. B., Pasquini, L., Riudavets, M., López-Costa, J. J., Villegas, A., Troncoso, J. C., et al. (2010). Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer’s disease. Neurobiol. Aging 31, 1743-1757. doi: 10.1016/j.neurobiolaging.2008.09.016.
22. Eberling, J. L., Jagust, W. J., Reed, B. R., and Baker, M. G. (1992). Reduced temporal lobe blood flow in Alzheimer’s disease. Neurobiol. Aging 13, 483-491. doi: 10.1016/0197-4580(92)90076-a.
23. Farkas, E., and Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog. Neurobiol. 64, 575-611. doi: 10.1016/s0301-0082(00)00068-x.
24. Fuentealba, R. A., Liu, Q., Zhang, J., Kanekiyo, T., Hu, X., Lee, J. M., et al. (2010). Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One 5:e11884. doi: 10.1371/journal.pone.0011884.
25. Ghersi-Egea, J. F., Gorevic, P. D., Ghiso, J., Frangione, B., Patlak, C. S., and Fenstermacher, J. D. (1996). Fate of cerebrospinal fluid-borne amyloid β-peptide:Rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 67, 880-883. doi: 10.1046/j.1471-4159.1996.67020880.x.
26. González-Marrero, I., Castañeyra-Ruiz, L., González-Toledo, J. M., Castañeyra-Ruiz, A., de Paz-Carmona, H., Castro, R., et al. (2013). High blood pressure effects on the blood to cerebrospinal fluid barrier and cerebrospinal fluid protein composition: a two-dimensional electrophoresis study in spontaneously hypertensive rats. Int. J. Hypertens. 2013:164653. doi: 10.1155/2013/164653.
27. Gu, H., Zhong, Z., Jiang, W., Du, E., Dodel, R., Liu, J., et al. (2014). The role of choroid plexus in IVIG-induced beta-amyloid clearance. Neuroscience 270, 168-176. doi: 10.1016/j.neuroscience.2014.04.011.
28. Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., et al. (1995). The Swedish mutation causes early-onset alzheimer’s disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 1291-1296. doi: 10.1038/nm1295-1291.
29. Hammad, S. M., Ranganathan, S., Loukinova, E., Twal, W. O., and Argraves, W. S. (1997). Interaction of apolipoprotein J-amyloid betapeptide complex with low density lipoprotein receptor related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J. Biol. Chem. 272, 18644-18649. doi: 10.1074/jbc.272.30.18644.
30. Head, E., Pop, V., Sarsoza, F., Kayed, R., Beckett, T. L., Studzinski, C. M., et al. (2010). Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines. J. Alzheimers Dis. 20, 637-646. doi: 10.3233/JAD-2010-1397.
31. Hedberg, M. M., Clos, M. V., Ratia, M., Gonzalez, D., Lithner, C. U., Camps, P., et al. (2010). Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neurodegener Dis. 7, 379-388. doi: 10.1159/000287954.
32. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, H., and Ihara, Y. (1994). Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is A_42(43). Neuron 13, 45-53. doi: 10.1016/0896-6273(94)90458-8.
33. Ji, Y., Permanne, B., Sigurdsson, E. M., Holtzman, D. M., and Wisniewski, T. (2001). Amyloid beta 40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. J. Alzheimers Dis. 3, 23-30.
34. Johanson, C. (2003). "The choroid plexus-CSF nexus: gateway to the brain," in Neuroscience in Medicine, ed P. M. Conn (Totowa, NJ: Humana Press Inc.) 165-195.
35. Johanson, C. E., Duncan, J. A., Klinge, P. M., Brinker, T., Stopa, E. G., and Silverberg, G. D. (2008). Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 5:10.doi: 10.1186/1743-8454-5-10.
36. Johanson, C., McMillan, P., Tavares, R., Spangenberger, A., Duncan, J., Silverberg, G., et al. (2004). Homeostatic capabilities of the choroid plexus epithelium in Alzheimer’s disease. Cerebrospinal Fluid Res. 1:3. doi: 10.1186/1743-8454-1-3.
37. Kalani, M. Y., Filippidis, A. S., and Rekate, H. L. (2012). Hydrocephalus and aquaporins: the role of aquaporin-1. Acta Neurochir. Suppl. 113, 51-54.doi: 10.1007/978-3-7091-0923-6_11.
38. Kalaria, R. N., and Pax, A. B. (1995). Increased collagen content of cerebral microvessels in Alzheimer’s disease. Brain Res. 705, 349-352. doi: 10.1016/0006-8993(95)01250-8.
39. Krzyzanowska, A., and Carro, E. (2012). Pathological alteration in the choroid plexus of Alzheimer’s disease: implication for new therapy approaches. Front. Pharmacol. 3:75. doi: 10.3389/fphar.2012.00075.
40. LaFerla, F. M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer’s disease. Nat. Rev. Neurosci. 8, 499-509. doi: 10.1038/nrn2168.
41. Lu, Y., Barton, H. A., Leung, L., Zhang, L., Hajos-Korcsok, E., Nolan, C. E., et al. (2013). Cerebrospinal fluid β-Amyloid turnover in the mouse, dog, monkey and human evaluated by systematic quantitative analyses. Neurodegener. Dis. 12, 36-50. doi: 10.1159/000341217.
42. Maruyama, K., Tagawa, K., Kawamura, Y., Asada, H., Ishiura, S., and Obata, K. (1995). Secretion of Alzheimer beta/A4 protein (1-40) and intracellular retention of beta/A4 protein (1-42) in transfected COS cells. Biochem. Biophys. Res. Commun. 207, 971-977.
43. Masseguin, C., LePanse, S., Corman, B., Verbavatz, J. M., and Gabrion, J. (2005). Aging affects choroidal proteins involved in CSF production in Sprague-Dawley rats. Neurobiol. Aging 26, 917-927. doi: 10.1016/j.neurobiolaging.2004.07.013.
44. Mattsson, N., Tosun, D., Insel, P. S., Simonson, A., Jack, C. R. Jr., Beckett, L. A., et al. (2014). Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment. Brain 137, 1550-1561. doi: 10.1093/brain/awu043.
45. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., et al. (2010). Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774. doi: 10.1126/science.1197623.
46. O’Brien, R. J., and Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer’s disease. Annu. Rev. Neurosci. 34, 185-204. doi: 10.1146/annurev-neuro-061010-113613.
47. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B. P., and LaFerla, F. M. (2003a). Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiol. Aging 24, 1063-1070. doi: 10.1016/j.neurobiolaging.2003.08.012.
48. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., et al. (2003b). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. doi: 10.1016/s0896-6273(03)00434-3.
49. Ohnishi, T., Hoshi, H., Nagamachi, S., Jinnouchi, S., Flores, L. G. II, Futami, S., et al. (1995). High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J. Nucl. Med. 36, 1163-1169.
50. Omtri, R. S., Davidson, M. W., Arumugam, B., Poduslo, J. F., and Kandimalla, K. K. (2012). Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer’s drug discovery. Mol. Pharm. 9, 1887-1897. doi: 10.1021/mp200530q.
51. Pascale, C. L., Miller, M. C., Chiu, C., Boylan, M., Caralopoulos, I. N., Gonzalez, L., et al. (2011). Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS. 8:21. doi: 10.1186/2045-8118-8-21.
52. Preston, J. E., Wilson, M. R., and Chen, R. L. (2005). "Aging of the choroid plexus and CSF System: implications for neurodegeneration," in The Blood-Cerebrospinal Fluid Barrier, eds W. Zheng and A. Chodobski (Boca Raton, FL: Taylor and Francis Books), 361-376.
53. Redzic, Z. B., Preston, J. E., Duncan, J. A., Chodobski, A., and Szmydynger-Chodobska, J. (2005). The choroid plexus-cerebrospinal fluid system: from development to aging. Curr. Top. Dev. Biol. 71, 1-52. doi: 10.1016/s0070-2153(05)71001-2.
54. Riisøen, H. (1988). Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer’s disease. Acta Neurol. Scand. 78, 455-459. doi: 10.1111/j.1600-0404.1988.tb03687.x.
55. Sagare, A., Deane, R., Bell, R. D., Johnson, B., Hamm, K., Pendu, R., et al. (2007). Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 13, 1029-1031. doi: 10.3410/f.1091075.544461.
56. Sagare, A. P., Deane, R., Zetterberg, H., Wallin, A., Blennow, K., and Zlokovic, B. V. (2011). Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer’s disease. J. Alzheimer Dis. 24, 25-34. doi: 10.3233/JAD-2010-101248.
57. Savage, M. J., Kalinina, J., Wolfe, A., Tugusheva, K., Korn, R., Cash-Mason, T., et al. (2014). A sensitive Aβ oligomer assay discriminates Alzheimer’s and aged control cerebrospinal fluid. J. Neurosci. 34, 2884-2897. doi: 10.1523/JNEUROSCI.1675-13.2014.
58. Selkoe, D. J. (2001). Alzheimer’s disease: genes, proteins and therapy. Physiol. Rev. 81, 741-766. doi: 10.1007/springerreference:34009.
59. Serot, J. M., Bene, M. C., and Faure, G. C. (2003a). Choroid plexus, aging of the brain and Alzheimer’s disease. Front. Biosci. 8, 515-521. doi: 10.2741/1085.
60. Serot, J. M., Bene, M. C., and Faure, G. C. (2003b). Normal-pressure hydrocephalus and Alzheimer disease. J. Neurosurg. 99, 797-798. doi: 10.3171/jns.2003.99.4.0797.
61. Serot, J. M., Christmann, D., Dubost, T., and Couturier, M. (1997). Cerebrospinal fluid transthyretin: aging and late onset alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 63, 506-508. doi: 10.1136/jnnp.63.4.506.
62. Serot, J. M., Peltier, J., Fichten, A., Ledeme, N., Bourgeois, A. M., Jouanny, P., et al. (2011). Reduced CSF turnover and decreased ventricular Aβ42 levels are related. BMC Neurosci. 12:42. doi: 10.1186/1471-2202-12-42.
63. Serot, J. M., Zmudka, J., and Jouanny, P. (2012). A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset alzheimer’s disease. J. Alzheimer Dis. 30, 17-26. doi: 10.3233/JAD-2012-111964.
64. Silverberg, G. D., Heit, G., Huhn, S., Jaffe, R. A., Chang, S. D., Bronte-Stewart, H., et al. (2001). The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer’s type. Neurology 57, 1763-1766. doi: 10.1212/wnl.57.10.1763.
65. Silverberg, G. D., Mayo, M., Saul, T., Rubenstein, E., and McGuire, D. (2003). Alzheimer’s disease, normal-pressure hydrocephalus and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2, 506-511. doi: 10.1007/springerreference:34009.
66. Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., et al. (2010a). Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J. Neuropathol. Exp. Neurol. 69, 1034-1043. doi: 10.1097/nen.0b013e3181f46e25.
67. Silverberg, G. D., Miller, M. C., Messier, A. A., Majmudar, S., Machan, J. T., Donahue, J. E., et al. (2010b). Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J. Neuropathol. Exp. Neurol. 69, 98-108. doi: 10.1097/nen.0b013e3181c8ad2f.
68. Spector, R., and Johanson, C. E. (2013). Sustained choroid plexus function in human elderly and Alzheimer’s disease patients. Fluids Barriers CNS 10:28. doi: 10.1186/2045-8118-10-28.
69. Sterniczuk, R., Antle, M. C., LaFerla, F. M., and Dyck, R. H. (2010). Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: part 2. Behavioral and cognitive changes. Brain Res. 1348, 149-155. doi: 10.1016/j.brainres.2010.06.011.
70. Stoquart-ElSankari, S., Balédent, O., Gondry-Jouet, C., Makki, M., Godefroy, O., and Meyer, M. E. (2007). Aging effects on cerebral blood and cerebrospinal fluid flows. J. Cereb. Blood Flow Metab. 27, 1563-1572. doi: 10.1038/sj.jcbfm.9600462.
71. Szmydynger-Chodobska, J., Chodobski, J., and Johanson, C. E. (1994). Postnatal development changes in blood flow to choroid plexus and cerebral cortex of the rat. Am. J. Physiol. 266, 1488-1492.
72. Tang, Y. P., Haslam, S. Z., Conrad, S. E., and Sisk, C. L. (2004). Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. J. Alzheimers Dis. 6, 413-420.
73. Tang, Z., Pi, X., Chen, F., Shi, L., Gong, H., Fu, H., et al. (2012). Fifty percent reduced-dose cerebral CT perfusion imaging of Alzheimer’s disease: regional blood flow abnormalities. Am. J. Alzheimers Dis. Other Demen. 27, 267-274. doi: 10.1177/1533317512447885.
74. Thinakaran, G., and Koo, E. H. (2008). Amyloid precursor protein trafficking, processing and function. J. Biol. Chem. 283, 29615-29619. doi: 10.1074/jbc.r800019200.
75. Tsuchiya, M., Sako, K., Yura, S., and Yonemasu, Y. (1992). Cerebral blood flow and histopathological changes after permanent bilateral carotid artery ligation in Wistar rats. Exp. Brain Res. 89, 87-92. doi: 10.1007/bf00229004.
76. Wang, D. S., Dickson, D. W., and Malter, J. S. (2006). beta-Amyloid degradation and Alzheimer’s disease. J. Biomed. Biotechnol. 3, 584-606. doi: 10.1155/JBB/2006/58406.
77. Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., et al. (2001). Intraneuronal Ab accumulation precedes plaque formation in b-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306, 116-120. doi: 10.1016/s0304-3940(01)01876-6.
78. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., and Selkoe, D. J. (1999). Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517.
79. Wostyn, P., Audenaert, K., and De Deyn, P. P. (2011). Choroidal proteins involved in cerebrospinal fluid production may be potential drug targets for Alzheimer’s disease therapy. Perspect. Medicin. Chem. 5, 11-17. doi: 10.4137/pmc.s6509.
80. Youmans, K. L., Tai, L. M., Kanekiyo, T., Stine, W. B. Jr., Michon, S. C., Nwabuisi-Heath, E., et al. (2012). Intraneuronal Abeta detection in 5xFAD mice by a new Abeta-specific antibody. Mol. Neurodegener. 7:8. doi: 10.1186/1750-1326-7-8.
81. Zwolinski, B. J., Eyring, H., and Reese, C. E. (1948). Diffusion and membrane permeability. J. Phys. Chem. 53, 1426-1453.